{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:09:36Z","timestamp":1788952176730,"version":"build-2803163510"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/ckj\/sfy062","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T07:56:53Z","timestamp":1530172613000},"page":"433-436","source":"Crossref","is-referenced-by-count":7,"title":["Are oxyphil cells responsible for the ineffectiveness of cinacalcet hydrochloride in haemodialysis patients?"],"prefix":"10.1093","volume":"12","author":[{"given":"Jacques","family":"Rottembourg","sequence":"first","affiliation":[{"name":"Department of Nephrology, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Menegaux","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,23]]},"reference":[{"key":"2019053109302579500_sfy062-B1","first-page":"295","article-title":"Hyperparathyroidism and dialysis vintage","volume":"54","author":"Chertow","year":"2000","journal-title":"Clin Nephrol"},{"key":"2019053109302579500_sfy062-B2","first-page":"S1","article-title":"National Kidney Foundation. K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42(4 Suppl 3)","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2019053109302579500_sfy062-B3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"key":"2019053109302579500_sfy062-B4","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1046\/j.1523-1755.63.s85.22.x","article-title":"Calcimimetic agents: review and perspectives","volume":"63(Suppl 85)","author":"Urena","year":"2003","journal-title":"Kidney Int"},{"key":"2019053109302579500_sfy062-B5","first-page":"527","article-title":"Cinacalcet treatment for secondary hyperparathyroidism in dialysis patients in real-world clinical practice \u2013 the ECHO observational study: French experience","volume":"8","author":"Urena","year":"2012","journal-title":"Nephrol Ther"},{"key":"2019053109302579500_sfy062-B6","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2215\/CJN.02110310","article-title":"Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism","volume":"5","author":"Komaba","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019053109302579500_sfy062-B7","first-page":"104892","article-title":"Clinical benefits of an adherence monitoring program in the management of secondary hyperparathyroidism with cinacalcet: results of a prospective randomized controlled study","volume":"2013","author":"Forni Ogna","year":"2013","journal-title":"Bio Med Res Int"},{"key":"2019053109302579500_sfy062-B8","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"2019053109302579500_sfy062-B9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2215\/CJN.07050714","article-title":"A randomized trial of cinacalcet versus vitamin D analogs as monotherapy in secondary hyperparathyroidism (PARADIGM)","volume":"10","author":"Wetmore","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019053109302579500_sfy062-B10","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2215\/CJN.01040308","article-title":"Cinacalcet-HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results","volume":"3","author":"Fishbane","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019053109302579500_sfy062-B11","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1093\/ndt\/gfs018","article-title":"Paracalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study","volume":"27","author":"Ketteler","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2019053109302579500_sfy062-B12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.03591006","article-title":"The OPTIMA study: assessing a new cinacalcet (Sensipar\/Mimpara) treatment algorithm for secondary hyperparathyroidism","volume":"3","author":"Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019053109302579500_sfy062-B13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis","volume":"26","author":"Raggi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2019053109302579500_sfy062-B14","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/ndt\/gfs568","article-title":"Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism","volume":"28","author":"Urena-Torres","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2019053109302579500_sfy062-B15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/ndt\/gfn654","article-title":"Long-term treatment with Cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism","volume":"24","author":"Meola","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2019053109302579500_sfy062-B16","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia and quality of life in maintenance dialysis patients","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019053109302579500_sfy062-B17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.nefro.2015.10.006","article-title":"Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism","volume":"36","author":"de Francisco","year":"2016","journal-title":"Nefrologia"},{"key":"2019053109302579500_sfy062-B18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/jcp.20.4.591","article-title":"The parathyroid oxyphil cells","volume":"20","author":"Christie","year":"1967","journal-title":"J Clin Pathol"},{"key":"2019053109302579500_sfy062-B19","doi-asserted-by":"crossref","first-page":"E1499","DOI":"10.1210\/jc.2011-3366","article-title":"Differential gene expression by oxyphil cells of human parathyroid glands","volume":"97","author":"Ritter","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019053109302579500_sfy062-B20","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2215\/CJN.04150907","article-title":"Does vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of the parathyroid glands in refractory uremic hyperparthyroidism","volume":"3","author":"Lomonte","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019053109302579500_sfy062-B21","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.kint.2017.05.003","article-title":"Paracalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease","volume":"92","author":"Ritter","year":"2017","journal-title":"Kidney Int"},{"key":"2019053109302579500_sfy062-B22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jsbmb.2012.01.010","article-title":"Distribution and regulation of the 25-hydroxyvitamin D3 1\u03b1-hydroxylase in human parathyroid glands","volume":"130","author":"Ritter","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019053109302579500_sfy062-B23","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/jclinpath-2011-200100","article-title":"Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride","volume":"64","author":"Sumida","year":"2011","journal-title":"J Clin Pathol"},{"key":"2019053109302579500_sfy062-B24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbrc.2007.07.177","article-title":"Activation of calcium-sensing receptor accelerates apoptosis in hyperparathyroid cells","volume":"362","author":"Mizobuchi","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"2019053109302579500_sfy062-B25","first-page":"S13","article-title":"Control of parathyroid cell growth by calcimimetics","volume":"18(Suppl 3)","author":"Wada","year":"2003","journal-title":"Nephrol Dial Transplant"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/12\/3\/433\/28752484\/sfy062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T09:30:38Z","timestamp":1559295038000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/12\/3\/433\/5057645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,23]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,7,23]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfy062","relation":{},"ISSN":["2048-8513"],"issn-type":[{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2018,7,23]]}}}